Breaks Categories: News

WednesdayMay 24, 2017 12:55 pm

NetworkNewsBreaks – Jaguar Animal Health, Inc. (NASDAQ: JAGX) Shares Spike on New Mytesi® Video

Shares of Jaguar Animal Health (NASDAQ: JAGX) are up more than 8% this morning, likely trending higher on news that Napo Pharmaceuticals, Inc. has launched a Mytesi® video that highlights the challenges of living with HIV-related diarrhea. Jaguar has licensed worldwide veterinary rights to Mytesi®, which is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The video features commentary from people living with HIV/AIDS, describing the impact it has on their daily lives. “The active pharmaceutical ingredient in Mytesi®, crofelemer, is a first-in-class anti-secretory agent offering a natural solution…

Continue Reading

WednesdayMay 24, 2017 10:38 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Completes Acquisition of Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced the completion of its acquisition of Discount Indoor Garden Supply (“DIGS”). Under the terms of the agreement, SinglePoint has acquired a 90 percent stake in DIGS through a stock and cash transaction, further demonstrating the company’s ability to strategically expand its portfolio of investments in established, high-potential cannabis businesses. “This acquisition is an important one for SinglePoint and strengthens our footing in the cannabis industry,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “The acquisition of DIGS is phenomenal for the company's books. More importantly though are the…

Continue Reading

WednesdayMay 24, 2017 9:28 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Launch of ‘OptHemp’ Premium Hemp Health Product Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary Chinesehempoil.com Inc., this morning announced plans to launch its own premium hemp health product line, ‘OptHemp’, as well as its first private label product, OptHemp Ultra Premium Hemp Oil. “We believe that the desire for better quality of life in the Chinese community, coupled with fact that the aging population continues to grow, will lead to continued growth in the alternative health sector and increased demand for natural hemp-based health products,” Warren Wang, founder and CEO of CIIX, stated in the news release. “CIIX is confident that its OptHemp product…

Continue Reading

TuesdayMay 23, 2017 8:59 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Enters Letter of Intent to Acquire W Marketing, Inc.

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced its entry into a binding letter of intent to acquire W Marketing, Inc., a profitable, revenue-generating provider of National Electrical Codes (NECs) to the electrical and construction industries. Leveraging W Marketing’s nationwide network of electrical distributors, which includes bookstores, trade/vocational schools, universities, retail chains, specialty retailers and independent hardware stores, ProBility expects this acquisition to strengthen its financial position while allowing it to become one of the nation’s largest wholesalers of National Fire Protection Association (NFPA) electrical codes. “We are pleased to announce this corporate milestone and look forward…

Continue Reading

FridayMay 19, 2017 12:42 pm

NetworkNewsBreaks – Ethema Health Corp.’s (GRST) Seastone Facility Offers Range of Specialized Addiction Treatment Programs

Seastone of Delray – Drug Rehabilitation and Alcohol Treatment Center, owned and operated by Ethema Health Corporation (OTCQB: GRST) (formerly GreeneStone Healthcare Corporation), may be one of many substance abuse recovery and treatment facilities in Florida, but it stands out from the crowd due to the highly efficient individualized treatment options offered. Seastone is distinguished by a broad range of treatment programs – offered at varying intensities depending on the needs of the individual client - and careful attention paid to the individual client and family, ensuring a highly detailed assessment is conducted prior to the creation of a specialized…

Continue Reading

ThursdayMay 18, 2017 12:05 pm

NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Shares Surge on First vBloc® Neurometabolic Therapy Implant

EnteroMedics (NASDAQ: ETRM) shares are up 12% late-morning following news that the first implant of the company's vBloc® Neurometabolic Therapy was successfully completed at the McGuire Veterans Affairs Medical Center (Richmond VAMC) in Richmond, Virginia, earlier this week. The pacemaker-like device works to control sensations of hunger to enable patients to control their appetite and lose weight. "With our first implant at the Richmond VAMC, we are making vBloc accessible to an even larger portion of the men and women who have served our country selflessly and are in need of solutions to address their obesity. Through our previously announced…

Continue Reading

WednesdayMay 17, 2017 12:55 pm

NetworkNewsBreaks – Cemtrex (NASDAQ: CETX) Shares Climb on Report of Over $21M in Orders During April

Cemtrex (NASDAQ: CETX) shares surged more than 30% this morning on news that during the month of April the company received more than $21 million in new orders. Among the contracts placed during this period is a three-year agreement worth approximately $15 million for the company’s electronics manufacturing services business in Germany. The contract is the largest order placed with the company to date. “We are experiencing a build out of customer activity as our sales and marketing team ramps up their outreach. The activity we are seeing in our sales pipeline validates our expanded investments in sales and marketing…

Continue Reading

WednesdayMay 17, 2017 10:09 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Stake in Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its entry into a Letter of Intent with Discount Indoor Garden Supply (“DIGS”). Per the terms of the LOI, SinglePoint will acquire 90 percent of DIGS in a stock and cash transaction. The company anticipates that the acquisition will bring immediate revenues to SinglePoint while positioning it as a leader in online products, retail stores, cannabis consulting and equipment in California. “We are committed to identifying and making investments that will strengthen both parties' position in the cannabis industry while building SinglePoint's corporate value,” Greg Lambrecht, CEO of SinglePoint, stated…

Continue Reading

WednesdayMay 17, 2017 9:49 am

NetworkNewsBreaks – SRAX (NASDAQ: SRAX) Presenting at 18th Annual B. Riley Co. Investor Conference on May 24

Internet advertising company SRAX (NASDAQ: SRAX) this morning announced plans to present at the 18th Annual B. Riley Co. Investor Conference, an invitation-only conference offering premier networking and business development opportunities with an attractive beachfront setting. The company’s presentation is scheduled to take place on Wednesday, May 24, 2017, at 3:25 p.m. PT at the newly-renovated Loews Santa Monica Beach Hotel in Santa Monica, California. In addition to the company’s presentation, SRAX CEO Christopher Miglino and CFO J.P. Hannan will be hosting one-on-one meetings with investors throughout the day. Interested parties should contact Kirsten Chapman at [email protected] or 415-433-3777 to…

Continue Reading

WednesdayMay 17, 2017 9:28 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Announces Treatment of First Patient in Phase 2 Trial of PRO 140 for Graft versus Host Disease

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced the treatment of the first patient in its phase 2 clinical trial of PRO 140 for Graft versus Host Disease (GvHD), which represents its leading immunologic indication for the candidate. The multicenter, 60-patient study aims to evaluate the safety and efficacy of PRO 140 in treating GvHD, a potentially life-threatening complication affecting patients requiring a bone marrow transplant due to depleted immune systems. Currently, these transplant patients have just a 40-60% one-year survival rate, and relapsed GvHD is the leading cause of death. “We selected the transplantation indication called GvHD as…

Continue Reading